Gastroenteropancreatic neuroendocrine tumors: Role of surgery

被引:4
|
作者
Sauvanet, Alain [1 ]
机构
[1] Univ Paris Diderot, Hop Beaujon, AP HP, Dept HPB Surg,PMAD, 100 Blvd Gen Leclerc, F-92110 Clichy, France
关键词
Gastroenteropancreatic neuroendocrine tumors; Pancreatectomy; Pancreatic insufficiency; Observation; LYMPH-NODE INVOLVEMENT; ENDOCRINE TUMORS; SURGICAL-MANAGEMENT; PANCREATIC INSUFFICIENCY; SHORT-TERM; RESECTION; SURVIVAL; CM; LYMPHADENECTOMY; METAANALYSIS;
D O I
10.1016/j.ando.2019.04.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural history of gastroenteropancreatic (GEP) Neuroendocrine tumors (NETs) is better and better known so indications of surgery are presently selective. Surgical resection, but also endoscopic resection and observation, can be proposed for gastric NETs according to presentation, size and grade. For small bowel NETs, resection is frequently needed but should obtain the best compromise between radicality and postoperative functional disorders. Appendiceal NETs are frequently diagnosed by appendectomy for appendicitis, but some patients at high risk for lymph node metastasis and recurrence should be reoperated for radical resection. Rectal NETs are often diagnosed incidentally; the smallest (< 1 cm) can be resected endoscopically but the most aggressive need a oncological proctectomy. Pancreatic NETs represent a wide spectrum, ranging from fully benign tumors to very aggressive ones. lnsulinomas are mostly benign, responsible for incapacitating symptoms despite medical treatment, and should ideally be treated by parenchyma sparing resection, mainly enucleation. Conversely, symptoms of gastrinomas are efficiently treated medically but their resection needs an oncological approach. Nonfunctioning PNETs are more and more frequently and incidentally discovered. According to their size, presentation and patient's characteristics, they need a resection (oncological or parenchyma-sparing) or a close observation. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [41] Update in the management of gastroenteropancreatic neuroendocrine tumors
    Sedlack, Andrew J. H.
    Varghese, Diana Grace
    Naimian, Amirkia
    Anari, Pouria Yazdian
    Bodei, Lisa
    Hallet, Julie
    Riechelmann, Rachel P.
    Halfdanarson, Thor
    Capdevilla, Jaume
    Del Rivero, Jaydira
    CANCER, 2024, 130 (18) : 3090 - 3105
  • [42] Novel Agents in Gastroenteropancreatic Neuroendocrine Tumors
    Stevenson, Ryan
    Libutti, Steven K.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (02): : 152 - 154
  • [43] Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors
    Singh, Simron
    Chan, David L.
    Moody, Lesley
    Liu, Ning
    Fischer, Had As D.
    Austin, Peter C.
    Segelov, Eva
    JAMA ONCOLOGY, 2018, 4 (04) : 583 - 585
  • [44] Liver Transplantation for Gastroenteropancreatic Neuroendocrine Tumors
    Figueira, E. R. R.
    Rocha Filho, J. A.
    Haddad, L. B. P.
    Oliveira, A. C.
    Okubo, J.
    Fernandes, A. G. V.
    D'Albuquerque, L. A. C.
    NEUROENDOCRINOLOGY, 2016, 103 : 97 - 97
  • [46] Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
    Phan, Alexandria T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (12) : 3 - 5
  • [47] Hereditary neuroendocrine tumors of the gastroenteropancreatic system
    Martin Anlauf
    Nele Garbrecht
    Juliane Bauersfeld
    Anja Schmitt
    Tobias Henopp
    Paul Komminoth
    Philipp U. Heitz
    Aurel Perren
    Günter Klöppel
    Virchows Archiv, 2007, 451 : 29 - 38
  • [48] Prognostic Factors in Gastroenteropancreatic Neuroendocrine Tumors
    Srirajaskanthan, R.
    Toumpanakis, C.
    Desai, K.
    Warner, B.
    Subash, S.
    Caplin, M. E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 135 - 135
  • [49] Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors
    Kenney, Lisa M.
    Hughes, Marybeth
    CANCERS, 2025, 17 (03)
  • [50] Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors
    Venkata K. Pokuri
    Mei Ka Fong
    Renuka Iyer
    Current Oncology Reports, 2016, 18